Table 2 Overview of laboratory investigations in Patient 2

WBC (×10⁹/L)

3.50–9.50

5.60

5.69

7.84

10.01

6.30

 GR%

40–75

89

45

24

21

38

 GR# (×10⁹/L)

1.80–6.30

2.55

1.88

2.14

2.37

 LY%

20–50

8

31

50

66

56

 LY# (×10⁹/L)

1.10–3.20

1.76

3.89

6.62

3.53

 HGB (g/L)

115–150

97

89

91

81

87

 PLT (×10⁹/L)

125–350

172

104

146

111

409

 ALT (U/L)

9.0–50.0

143

 AST (U/L)

15.0–40.0

96

 LDH (U/L)

120–250

638

 HBD (U/L)

72.0–182.0

441

 Ca (mmol/L)

2.25–2.67

1.87

1.95

2.01

2.17

 ALB (g/L)

40.0–55.0

34.2

 Ferritin (μg/L)

20.0–200.0

444.6

 CRP (mg/L)

0.00–3.00

11.90

 BUN (mmol/L)

2.6–7.5

3.41

3.38

2.73

3.32

 Scr (μmol/L)

50–80

44

58.6

50

35.6

 Proteinuria (g/24 h)

-, 0–0.15

2+

1+

3+

MP - Ab

< 1:40

1:80

IgM capture ELISA anti- Hantaan virus

–

/

/

/

+